Wealth Enhancement Advisory Services
GILD icon

Wealth Enhancement Advisory Services’s Gilead Sciences GILD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.3M Buy
603,836
+114,066
+23% +$15M 0.11% 170
2026
Q1 		$55.7M Sell
489,770
-143,415
-23% -$20.1M 0.11% 166
2025
Q4 		$77.2M Buy
633,185
+37,949
+6% +$4.61M 0.1% 188
2025
Q3 		$69.5M Buy
595,236
+111,218
+23% +$12.6M 0.11% 180
2025
Q2 		$54.1M Buy
484,018
+191,052
+65% +$20.3M 0.09% 215
2025
Q1 		$32.8M Buy
292,966
+13,194
+5% +$1.36M 0.06% 285
2024
Q4 		$25.8M Sell
279,772
-43,239
-13% -$3.89M 0.05% 318
2024
Q3 		$27.1M Buy
323,011
+36,895
+13% +$2.82M 0.06% 301
2024
Q2 		$19.6M Buy
286,116
+33,162
+13% +$2.21M 0.05% 336
2024
Q1 		$18.5M Sell
252,954
-10,675
-4% -$821K 0.05% 338
2023
Q4 		$21.4M Buy
263,629
+48,509
+23% +$3.77M 0.06% 287
2023
Q3 		$16.1M Buy
215,120
+158,912
+283% +$12.2M 0.05% 316
2023
Q2 		$4.33M Buy
56,208
+290
+0.5% +$23.1K 0.05% 141
2023
Q1 		$4.64M Buy
+55,918
New +$4.63M 0.05% 141
2022
Q2 		– Sell
-102,618
Closed -$6.23M – 346
2022
Q1 		$6.23M Buy
102,618
+6,150
+6% +$393K 0.08% 118
2021
Q4 		$6.58M Buy
+96,468
New +$6.64M 0.09% 99
2020
Q2 		– Sell
-16,784
Closed -$1.32M – 227
2020
Q1 		$1.32M Buy
+16,784
New +$1.16M 0.05% 142
2019
Q3 		– Sell
-53,052
Closed -$3.6M – 212
2019
Q2 		$3.6M Buy
+53,052
New +$3.49M 0.16% 55
2018
Q1 		– Sell
-12,335
Closed -$975K – 158
2017
Q4 		$975K Buy
12,335
+188
+2% +$14.3K 0.07% 114
2017
Q3 		$998K Sell
12,147
-35,843
-75% -$2.74M 0.08% 96
2017
Q2 		$3.31M Buy
47,990
+33,962
+242% +$2.26M 0.31% 47
2017
Q1 		$943K Buy
+14,028
New +$986K 0.1% 88
2016
Q3 		– Sell
-13,094
Closed -$1.09M – 153
2016
Q2 		$1.09M Buy
13,094
+1,771
+16% +$157K 0.2% 106
2016
Q1 		$1.06M Buy
11,323
+765
+7% +$69K 0.21% 99
2015
Q4 		$1.07M Buy
10,558
+1,404
+15% +$146K 0.27% 63
2015
Q3 		$923K Buy
9,154
+1,060
+13% +$118K 0.28% 71
2015
Q2 		$948K Buy
8,094
+975
+14% +$107K 0.29% 53
2015
Q1 		$699K Buy
7,119
+956
+16% +$97.1K 0.27% 77
2014
Q4 		$581K Buy
+6,163
New +$637K 0.23% 83

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Wealth Enhancement Advisory Services's GILD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $15M and bringing the position to 603,836 shares worth $65.3M. The position accounts for 0.11% of the portfolio, ranked #170.

Wealth Enhancement Advisory Services first reported a position in GILD in Q4 2014 and has held it in 29 quarters since. The position peaked at $77.2M in Q4 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 603,836 shares of Gilead Sciences worth $65.3M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 114,066 Gilead Sciences shares in Q2 2026, an estimated $15M.
  • Gilead Sciences made up 0.11% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #170 holding.
  • Wealth Enhancement Advisory Services first reported a position in Gilead Sciences in Q4 2014 and has held it in 29 quarters since.
  • Wealth Enhancement Advisory Services's Gilead Sciences position peaked at $77.2M in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.